Belgium· BE-AMP-SAM543866-00
Waylivra 285 mg
A volanesorsen product containing volanesorsen sodium, registered in Belgium by Akcea Therapeutics Ireland. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Volanesorsen is registered in 11 of 19 countries.
Countries holding a registration under ATC C10AX18 (volanesorsen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Volanesorsen · ATC C10AX18
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Volanesorsen Sodium
- Manufacturer
- Akcea Therapeutics Ireland
- Country
- Belgium (BE)
- ATC code
- C10AX18
- ATC class
- Volanesorsen
- Defined daily dose
- 20 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Volanesorsen in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaWAYLIVRAAkcea Therapeutics Ireland Ltd, Dublin
- SwedenWaylivra 285 mg Injektionsvätska, lösning i förfylld sprutaAkcea Therapeutics Ireland Ltd
- FinlandWaylivraAkcea Therapeutics Ireland Ltd
- IrelandWaylivra 285 mg Solution for injectionAkcea Therapeutics Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Waylivra
- Liechtenstein · Waylivra
- Norway · Waylivra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eeeb8c53-ca27-4572-aff1-199f419a5ad0 GET /v1/drugs/eeeb8c53-ca27-4572-aff1-199f419a5ad0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Waylivra 285 mg",
"name_fr": "Waylivra 285 mg",
"name_nl": "Waylivra 285 mg",
"amp_code": "SAM543866-00",
"strengths": [
"200.0000",
"190.0000"
],
"pack_count": 2,
"substances": [
"Volanesorsen Sodium",
"Volanesorsen",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Volanesorsen",
"authorisation_numbers": [
"EU/1/19/1360/001",
"EU/1/19/1360/002"
]
}See everything about volanesorsen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.